Candriam Equities L Oncology Impact, V - Capitalisation/  LU2425425506  /

Fonds
NAV2024-05-30 Chg.+1.6799 Type of yield Investment Focus Investment company
1,791.2200GBP +0.09% reinvestment Equity Worldwide Candriam